4//SEC Filing
Curet Myriam 4
Accession 0001632901-25-000004
CIK 0001035267other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 7:48 PM ET
Size
25.1 KB
Accession
0001632901-25-000004
Insider Transaction Report
Form 4
Curet Myriam
EVP & Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-28$242.34/sh+5,030$1,218,954→ 5,383 total - Exercise/Conversion
Common Stock
2025-10-28$208.90/sh+1,379$288,073→ 1,732 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-28−1,379→ 626 totalExercise: $208.90Exp: 2029-08-28→ Common Stock (1,379 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-29−125→ 501 totalExercise: $208.90Exp: 2029-08-28→ Common Stock (125 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-28−5,030→ 0 totalExercise: $242.34Exp: 2030-08-28→ Common Stock (5,030 underlying) - Exercise/Conversion
Common Stock
2025-10-28$229.39/sh+1,153$264,487→ 1,506 total - Sale
Common Stock
2025-10-28$548.43/sh−1,379$756,279→ 353 total - Exercise/Conversion
Common Stock
2025-10-29$208.90/sh+125$26,113→ 125 total - Sale
Common Stock
2025-10-29$543.00/sh−125$67,875→ 0 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2025-10-28−1,153→ 1,676 totalExercise: $229.39Exp: 2030-02-27→ Common Stock (1,153 underlying) - Sale
Common Stock
2025-10-28$548.43/sh−5,030$2,758,580→ 353 total - Sale
Common Stock
2025-10-28$548.43/sh−1,153$632,334→ 353 total
Holdings
- 353(indirect: By Trust)
Common Stock
Footnotes (4)
- [F1]The transaction took place in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on July 29, 2026.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $545.57 to $551.71 as follows: 1,173 shares sold at $545.57 to $546.54; 2,460 shares sold at $546.69 to $547.63; 314 shares sold at $547.72 to $548.68; 2,610 shares sold at $549.26 to $550.21; 1,000 shares sold at $550.39 to $551.04; 5 shares sold at $551.71. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
- [F4]12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
Documents
Issuer
INTUITIVE SURGICAL INC
CIK 0001035267
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001632901
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 7:48 PM ET
- Size
- 25.1 KB